<?xml version="1.0" encoding="UTF-8" standalone="yes"?>

<!-- Copyright (c) 2004-2026 Broad Institute, Inc., Massachusetts Institute of Technology, and Regents of the University of California.  All rights reserved.
     See license terms at www.gsea-msigdb.org/gsea/license_terms_list. Please note that certain gene sets have special access terms.
-->
<MSIGDB BUILD_DATE="Jan 29, 2026" VERSION="2026.1.Hs" NAME="export">
    <GENESET STANDARD_NAME="LIN_MELANOMA_COPY_NUMBER_UP" SYSTEMATIC_NAME="M346" HISTORICAL_NAMES="" PMID="18245465" AUTHORS="Lin WM,Baker AC,Beroukhim R,Winckler W,Feng W,Marmion JM,Laine E,Greulich H,Tseng H,Gates C,Hodi FS,Dranoff G,Sellers WR,Thomas RK,Meyerson M,Golub TR,Dummer R,Herlyn M,Getz G,Garraway LA" GEOID="GSE2631" EXACT_SOURCE="Table 1" GENESET_LISTING_URL="" EXTERNAL_DETAILS_URL="" CHIP="HUMAN_GENE_SYMBOL" CONTRIBUTOR="Jessica Robertson" CONTRIBUTOR_ORG="MSigDB Team" DESCRIPTION_BRIEF="Candidate genes in significant regions of chromosomal copy number gains in a panel of melanoma samples." DESCRIPTION_FULL="The classification of human tumors based on molecular criteria offers tremendous clinical potential; however, discerning critical and druggable effectors on a large scale will also require robust experimental models reflective of tumor genomic diversity. Here, we describe a comprehensive genomic analysis of 101 melanoma short-term cultures and cell lines. Using an analytic approach designed to enrich for putative driver events, we show that cultured melanoma cells encompass the spectrum of significant genomic alterations present in primary tumors. When annotated according to these lesions, melanomas cluster into subgroups suggestive of distinct oncogenic mechanisms. Integrating gene expression data suggests novel candidate effector genes linked to recurrent copy gains and losses, including both phosphatase and tensin homologue (PTEN)-dependent and PTEN-independent tumor suppressor mechanisms associated with chromosome 10 deletions. Finally, sample-matched pharmacologic data show that FGFR1 mutations and extracellular signal-regulated kinase (ERK) activation may modulate sensitivity to mitogen-activated protein kinase/ERK kinase inhibitors. Genetically defined cell culture collections therefore offer a rich framework for systematic functional studies in melanoma and other tumors." TAGS="" MEMBERS="AP3S2,ARL4A,ARNT,ATP9A,BRAF,C6orf146,C6orf201,C8orf32,CCND1,CDC42SE1,CDYL,COPG2,CPA1,CTNND2,DDX11,DERL1,DNAH5,DNM1L,ECM1,ENSA,EP300,FADD,FAM60A,FAM63A,FARS2,FGF19,FGF3,FGF4,FLJ42258,IDH2,IQGAP1,KIAA1618,KLF14,KRAS,KU-MEL-3,LASS2,LYRM4,MEST,MGC15523,MITF,MKRN1,MLLT11,MRPL9,MRPS35,MYC,NAGA,NDUFB2,NFATC2,ORAOV1,PECI,PIK4CB,PIP5K1A,PMM1,POGZ,POLG,PRPF4B,PRUNE,PSMB4,PSMD4,RFX5,RNF139,RPP40,SALL4,SCIN,SETDB1,TARSL1,TBC1D16,TMEM16A,TRIO,TSGA14,WDR67,YARS2,ZFP64" MEMBERS_SYMBOLIZED="ANO1,AP3S2,ARL4A,ARNT,ATP9A,BRAF,CCND1,CDC42SE1,CDYL,CEP41,CERS2,COPG2,CPA1,CTNND2,DDX11,DERL1,DNAH5,DNM1L,ECI2,ECM1,ENSA,EP300,FADD,FAM217A,FARS2,FGF19,FGF3,FGF4,IDH2,IQGAP1,KLF14,KRAS,KU-MEL-3,LTO1,LYRM4,MEST,MINDY1,MITF,MKRN1,MLLT11,MRPL9,MRPS35,MYC,NAGA,NDUFB2,NFATC2,NTAQ1,PI4KB,PIP5K1A,PMM1,POGZ,POLG,PRP4K,PRUNE1,PSMB4,PSMD4,RFX5,RNF139,RNF213,RPP40,SALL4,SCIN,SETDB1,SINHCAF,SLC38A10,TARS2,TBC1D16,TBC1D31,TEX56P,TRIO,YARS2,ZFP64" MEMBERS_EZID="10059,10079,10124,10239,10455,10667,10799,10962,11236,124565,125058,1357,136259,1501,1663,1767,1893,2029,2033,220064,222826,2248,2249,23126,23608,26958,29956,3418,3845,404220,405,4232,4286,4609,4668,4708,4773,497048,51067,5298,5372,5428,55093,55107,55734,55793,56882,5692,5710,57128,57167,57674,58497,58516,595,5993,60488,65005,673,7204,79139,80222,8394,85477,8772,8826,8899,93594,9425,95681,9869,9965" MEMBERS_MAPPING="AP3S2,AP3S2,10239|ARL4A,ARL4A,10124|ARNT,ARNT,405|ATP9A,ATP9A,10079|BRAF,BRAF,673|C6orf146,FAM217A,222826|C6orf201,TEX56P,404220|C8orf32,NTAQ1,55093|CCND1,CCND1,595|CDC42SE1,CDC42SE1,56882|CDYL,CDYL,9425|COPG2,COPG2,26958|CPA1,CPA1,1357|CTNND2,CTNND2,1501|DDX11,DDX11,1663|DERL1,DERL1,79139|DNAH5,DNAH5,1767|DNM1L,DNM1L,10059|ECM1,ECM1,1893|ENSA,ENSA,2029|EP300,EP300,2033|FADD,FADD,8772|FAM60A,SINHCAF,58516|FAM63A,MINDY1,55793|FARS2,FARS2,10667|FGF19,FGF19,9965|FGF3,FGF3,2248|FGF4,FGF4,2249|FLJ42258,null,null|IDH2,IDH2,3418|IQGAP1,IQGAP1,8826|KIAA1618,RNF213,57674|KLF14,KLF14,136259|KRAS,KRAS,3845|KU-MEL-3,KU-MEL-3,497048|LASS2,CERS2,29956|LYRM4,LYRM4,57128|MEST,MEST,4232|MGC15523,SLC38A10,124565|MITF,MITF,4286|MKRN1,MKRN1,23608|MLLT11,MLLT11,10962|MRPL9,MRPL9,65005|MRPS35,MRPS35,60488|MYC,MYC,4609|NAGA,NAGA,4668|NDUFB2,NDUFB2,4708|NFATC2,NFATC2,4773|ORAOV1,LTO1,220064|PECI,ECI2,10455|PIK4CB,PI4KB,5298|PIP5K1A,PIP5K1A,8394|PMM1,PMM1,5372|POGZ,POGZ,23126|POLG,POLG,5428|PRPF4B,PRP4K,8899|PRUNE,PRUNE1,58497|PSMB4,PSMB4,5692|PSMD4,PSMD4,5710|RFX5,RFX5,5993|RNF139,RNF139,11236|RPP40,RPP40,10799|SALL4,SALL4,57167|SCIN,SCIN,85477|SETDB1,SETDB1,9869|TARSL1,TARS2,80222|TBC1D16,TBC1D16,125058|TMEM16A,ANO1,55107|TRIO,TRIO,7204|TSGA14,CEP41,95681|WDR67,TBC1D31,93594|YARS2,YARS2,51067|ZFP64,ZFP64,55734" FILTERED_BY_SIMILARITY="" FOUNDER_NAMES="" REFINEMENT_DATASETS="" VALIDATION_DATASETS="" CATEGORY_CODE="C2" ORGANISM="Homo sapiens" SUB_CATEGORY_CODE="CGP"/>
</MSIGDB>
